gunter von minckwitz: selecting the neo-adjuvant treatment by molecular subtype:
Published 9 years ago • 111 plays • Length 14:05Download video MP4
Download video MP3
Similar videos
-
2:12
dr. von minckwitz on lessons learned from neoadjuvant trials in breast cancer
-
10:18
gunter von minckwitz: the phase iii natan study (gbg 36/abcsg xx)
-
13:18
sabcs2014: the phase iii ice study (ibandronate) - gunter von minckwitz
-
1:46
dr. gunter von minckwitz on pcr and outcomes in breast cancer
-
7:18
molecular evolution of breast cancer during neoadjuvant chemotherapy
-
21:46
kathy s. albain: patients with luminal a and b / her2 negative breast cancer
-
14:11
computational prediction of mhc anchor locations guide neoantigen identification & prioritization
-
1:14:39
bioinformatics workshop 2022 module 2: marker gene taxonomic analysis
-
5:40
mnova 15 - biosequence tools
-
12:59
multi-pass, single-molecule nanopore reading of long protein strands
-
24:19
session 10: emerging strategies in neoadjuvant treatment of patients with her2 positive early br...
-
1:02
it doesn't matter where cancer starts
-
1:59
dr. von minckwitz on pathologic complete response in breast cancer
-
5:43
neoadjuvant chemo vs cytoreductive surgery in oc
-
5:35
session 10: discussion: primary and adjuvant systemic therapy of early breast cancer:
-
0:26
identifying the need for neoadjuvant chemotherapy in stage i breast cancer
-
1:56:06
analysis of metagenomic data: marker gene based analysis
-
17:02
paul e. goss: extended adjuvant endocrine therapy in hormone-receptor bc
-
2:04
dnastar - multiple sequence alignments in megalign pro
-
1:02
evaluating the role of neoadjuvant chemotherapy and surgery in stage i tnbc
-
1:43:07
somatic mutations and annotations